• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MBP
Click for more information
3.23% 3.0¢

METABOLIC PHARMACEUTICALS LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
MBPChange of Company Name30/11/09
MBPFinal Director's Interest Notice23/11/09
MBPResults of Meeting23/11/09
MBPChairman's Address to Shareholders23/11/09
MBPNotice of General Meeting and Proxy Form17/11/09
MBPExercise of PolyNovo OptionPRICE SENSITIVE16/11/09
MBPDirector Appointment/Resignation16/11/09
MBPNotice of Annual General Meeting/Proxy Form21/10/09
MBPAnnual Report to shareholders21/10/09
MBPFull Year Statutory Accounts30/09/09
MBPPreliminary Final ReportPRICE SENSITIVE28/08/09
MBPMetabolic Signs Agreement with Phosphagenics Ltd13/08/09
MBPPOH signs agreement with Metabolic Pharmaceuticals LtdPRICE SENSITIVE13/08/09
MBPMarket UpdatePRICE SENSITIVE10/08/09
MBPMarket UpdatePRICE SENSITIVE14/05/09
MBPInitial Director's Interest Notice21/04/09
MBPInitial Director's Interest Notice21/04/09
MBPInitial Director's Interest Notice21/04/09
MBPInitial Director's Interest Notice21/04/09
MBPAppendix 3Z - P Lappin20/04/09
MBPAppendix 3Z20/04/09
MBPDirector Appointment/Resignation - Changes to Company Board20/04/09
MBPBecoming a substantial holder07/04/09
MBPCeasing to be a substantial holder07/04/09
MBPBecoming a substantial holder02/04/09
MBPDirector Appointment/Resignation31/03/09
MBPFinal Director's Interest Notice31/03/09
MBPCeasing to be a substantial holder31/03/09
MBPAppendix 3B10/03/09
MBPChanges to PolyNovo Board and Management06/03/09
MBPFirst NovoSorb Patent Granted in AustraliaPRICE SENSITIVE04/03/09
MBPHalf Yearly Report and AccountsPRICE SENSITIVE26/02/09
MBPChanges to Metabolic Chairman and Company Secretary23/02/09
MBPFinal Director's Interest Notice23/02/09
MBPChanges to Metabolic and PolyNovo Board02/02/09
MBPAppendix 3B30/01/09
MBPDetails of Company Address08/01/09
MBP +Metabolic invests $3.5 million for 60% of PolyNovo18/12/08
MBP +Metabolic Investment into PolyNovoPRICE SENSITIVE18/12/08
MBPAppendix 3B03/12/08
MBPProposed PolyNovo acquisition terminatedPRICE SENSITIVE01/12/08
MBPResults of Meeting27/11/08
MBPAGM Presentation27/11/08
MBPChairman AGM Address27/11/08
MBPChange of Company Name
30/11/09
MBPFinal Director's Interest Notice
23/11/09
MBPResults of Meeting
23/11/09
MBPChairman's Address to Shareholders
23/11/09
MBPNotice of General Meeting and Proxy Form
17/11/09
MBPExercise of PolyNovo Option
16/11/09PRICE SENSITIVE
MBPDirector Appointment/Resignation
16/11/09
MBPNotice of Annual General Meeting/Proxy Form
21/10/09
MBPAnnual Report to shareholders
21/10/09
MBPFull Year Statutory Accounts
30/09/09
MBPPreliminary Final Report
28/08/09PRICE SENSITIVE
MBPMetabolic Signs Agreement with Phosphagenics Ltd
13/08/09
MBPPOH signs agreement with Metabolic Pharmaceuticals Ltd
13/08/09PRICE SENSITIVE
MBPMarket Update
10/08/09PRICE SENSITIVE
MBPMarket Update
14/05/09PRICE SENSITIVE
MBPInitial Director's Interest Notice
21/04/09
MBPInitial Director's Interest Notice
21/04/09
MBPInitial Director's Interest Notice
21/04/09
MBPInitial Director's Interest Notice
21/04/09
MBPAppendix 3Z - P Lappin
20/04/09
MBPAppendix 3Z
20/04/09
MBPDirector Appointment/Resignation - Changes to Company Board
20/04/09
MBPBecoming a substantial holder
07/04/09
MBPCeasing to be a substantial holder
07/04/09
MBPBecoming a substantial holder
02/04/09
MBPDirector Appointment/Resignation
31/03/09
MBPFinal Director's Interest Notice
31/03/09
MBPCeasing to be a substantial holder
31/03/09
MBPAppendix 3B
10/03/09
MBPChanges to PolyNovo Board and Management
06/03/09
MBPFirst NovoSorb Patent Granted in Australia
04/03/09PRICE SENSITIVE
MBPHalf Yearly Report and Accounts
26/02/09PRICE SENSITIVE
MBPChanges to Metabolic Chairman and Company Secretary
23/02/09
MBPFinal Director's Interest Notice
23/02/09
MBPChanges to Metabolic and PolyNovo Board
02/02/09
MBPAppendix 3B
30/01/09
MBPDetails of Company Address
08/01/09
MBP +Metabolic invests $3.5 million for 60% of PolyNovo
18/12/08
MBP +Metabolic Investment into PolyNovo
18/12/08PRICE SENSITIVE
MBPAppendix 3B
03/12/08
MBPProposed PolyNovo acquisition terminated
01/12/08PRICE SENSITIVE
MBPResults of Meeting
27/11/08
MBPAGM Presentation
27/11/08
MBPChairman AGM Address
27/11/08
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.